Design Issues in Randomized Phase II/III TrialsKORN, Edward L; FREIDLIN, Boris; ABRAMS, Jeffrey S et al.Journal of clinical oncology. 2012, Vol 30, Num 6, pp 667-671, issn 0732-183X, 5 p.Article

Characterization and multiparameter analysis of visual adverse events in Irofulven single-agent Phase I and II trialsRAYMOND, Eric; KAHATT, Carmen; CULLEN, Michael et al.Clinical cancer research. 2004, Vol 10, Num 22, pp 7566-7574, issn 1078-0432, 9 p.Article

Journées de pharmacogie cliniqueThérapie (Paris). 1992, Vol 47, Num 5, pp 455-465, issn 0040-5957Conference Proceedings

Les ellipticines et aza-ellipticines = Ellipticins and aza-ellipticinsGISSELBRECHT, C; MARTY, M; MIGNOT, L et al.Actualités hématologiques. 1984, Vol 18, pp 193-207, issn 0567-8757Article

Lack of herbal supplement characterization in published randomized controlled trialsWOLSKO, Peter M; SOLONDZ, David K; PHILLIPS, Russell S et al.The American journal of medicine. 2005, Vol 118, Num 10, pp 1087-1093, issn 0002-9343, 7 p.Article

The benefits of participation in clinical trialsVAN DONGEN, J. A; VAN DE VELDE, C. J. H.European journal of surgical oncology. 1996, Vol 22, Num 6, pp 561-562, issn 0748-7983Article

Time to mandate data release and independent audits for all clinical trialsHAINES, Ian E; GABOR MIKLOS, George L.Medical journal of Australia. 2011, Vol 195, Num 10, pp 575-577, issn 0025-729X, 3 p.Article

Randomized Phase II Trials: Inevitable or Inadvisable?GAN, Hui K; GROTHEY, Axel; POND, Gregory R et al.Journal of clinical oncology. 2010, Vol 28, Num 15, pp 2641-2647, issn 0732-183X, 7 p.Article

Calculation of power for matched pair studies when randomization is by groupSHIPLEY, M. J; SMITH, P. G; DRAMAUX, M et al.International journal of epidemiology. 1989, Vol 18, Num 2, pp 457-461, issn 0300-5771, 5 p.Article

Clinical effectiveness: An approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differencesMOORE, R. A; DERRY, S; MCQUAY, H. J et al.Pain (Amsterdam). 2010, Vol 149, Num 2, pp 173-176, issn 0304-3959, 4 p.Article

First clinical trials of the Twente Photoacoustic Mammoscope (PAM)VAARTJES, Susanne E; VAN HESPEN, Johan C. G; KLAASE, Joost M et al.Progress in biomedical optics and imaging. 2007, Vol 6629, pp 662917.1-662917.12, issn 1605-7422, isbn 978-0-8194-6773-7, 1VolConference Paper

Time trialsCOWAP, Simon.Medical journal of Australia. 2005, Vol 183, Num 2, issn 0025-729X, p. 72Article

Generalising the results of trials to clinical practiceSEALE, J. Paul; GEBSKI, Val J; KEECH, Anthony C et al.Medical journal of Australia. 2004, Vol 181, Num 10, pp 558-560, issn 0025-729X, 3 p.Article

Practicalities and ethics of running clinical trials in paediatric oncology: the UK experience. CommentaryESTLIN, E. J; ABLETT, S; BLEYER, W. A et al.European journal of cancer (1990). 2001, Vol 37, Num 11, pp 1394-1401, issn 0959-8049Article

The attitudes of oncology physicians and nurses toward phase I, II, and III cancer clinical trialsJIE ZHANG; HONG ZHANG; CHUNHUA YU et al.Contemporary clinical trials. 2011, Vol 32, Num 5, pp 649-653, issn 1551-7144, 5 p.Article

Développement d'un médicament = The development of a drugAUTRET-LECA, E.Revue de médecine de Tours et du Centre-Ouest. 1999, Vol 33, Num 3, pp 107-108, issn 1247-0163Article

Séminaire de formation aux essais thérapeutiques en Hépato-Gastro-Entérologie C.R.E.G.G = Formation congress in clinical trials in hepato-gastro-enterologyPAILLE, F; GILLOIS, P; MOTTIER, D et al.Acta endoscopica. 1998, Vol 28, Num 4, pp 433-449, issn 0240-642X, SUPConference Paper

Guidelines for clinical evaluation of antiepileptic drugsEpilepsia (Copenhagen). 1989, Vol 30, Num 4, pp 400-408, issn 0013-9580Article

Flexibility of single-subject experimental designs. III: Using flexibility to design or modify experimentsCONNELL, P. J; THOMPSON, C. K.The Journal of speech and hearing disorders. 1986, Vol 51, Num 3, pp 214-225, issn 0022-4677Article

Comment faire évoluer le paradigme du développement clinique et son découpage en phases I, II, IIIBAMBERGER, Marion; MOORE, Nicholas; LECHAT, Philippe et al.Thérapie (Paris). 2011, Vol 66, Num 4, pp 327-330, issn 0040-5957, 4 p.Article

Flexibility of single-subject experimental designs. I: Review of the basics of single-subject designsMCREYNODS, L. V; THOMSON, C. K.The Journal of speech and hearing disorders. 1986, Vol 51, Num 3, pp 194-203, issn 0022-4677Article

Flexibility of single-subject experimental designs. II: Design selection and arrangement of experimental phasesKEARNS, K. P.The Journal of speech and hearing disorders. 1986, Vol 51, Num 3, pp 204-214, issn 0022-4677Article

Martin Arrowsmith's clinical trial: scientific precision and heroic medicineLÖWY, Ilana.Journal of the Royal Society of Medicine. 2010, Vol 103, Num 11, pp 461-466, issn 0141-0768, 6 p.Article

How to interpret figures in reports of clinical trialsPOCOCK, Stuart; TRAVISON, Thomas; WRUCK, Lisa et al.BMJ. British medical journal (International ed.). 2008, Vol 336, Num 7654, pp 1166-1169, issn 0959-8146, 4 p.Article

The conundrum of office-based clinical trialsSCOTT, Larry D.The American journal of gastroenterology. 2007, Vol 102, Num 2, pp 232-235, issn 0002-9270, 4 p.Article